TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC ENTERAL FEEDING FORMULA MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET CHALLENGE MATRIX
2.8 SECONDARY SOURCES
2.9 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 RISING NUMBER OF PRETERM BIRTH
3.1.2 GROWING NUMBER OF CHRONIC DISEASES
3.1.3 GROWING BUSINESS EXPANSION FOR NUTRITIONAL SUPPLY
3.1.4 GROWING NEED OF NUTRITIONAL CARE FOR GERIATRIC POPULATION
3.2 RESTRAINTS
3.2.1 RISK ASSOCIATED WITH THE ENTERAL TUBE FEEDING
3.2.2 STRICT REGULATION OF USAGE FOR PATIENTS SAFETY
3.3 OPPORTUNITIES
3.3.1 GROWTH IN HEALTHCARE EXPENDITURE OF DEVELOPING ECONOMIES
3.4 CHALLENGES
3.4.1 INSUFFICIENT REIMBURSEMENTS POLICIES
3.4.2 LACK OF TRAINED STAFF
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 ASIA-PACIFIC ENTERAL FEEDING FORMULA MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 STANDARD FORMULAS
6.2.1 MONOMERIC
6.2.2 POLYMERIC
6.3 DISEASE SPECIFIC
6.3.1 DIABETIC FORMULAS
6.3.2 RENAL FORMULAS
6.3.3 HEPATIC FORMULAS
6.3.4 PULMONARY FORMULAS
6.3.5 OTHERS
7 ASIA-PACIFIC ENTERAL FEEDING FORMULA MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 CRITICAL CARE
7.3 GASTROENTEROLOGY
7.4 ONCOLOGY
7.5 NEUROLOGY
7.6 DIABETES
7.7 OTHERS
8 ASIA-PACIFIC ENTERAL FEEDING FORMULA MARKET, BY TYPE OF TUBE FEEDING
8.1 OVERVIEW
8.2 GASTRIC TUBE FEEDING
8.3 NASOGASTRIC TUBE FEEDING
8.4 GASTROTOMY TUBE FEEDING
8.5 DUODENAL OR JEJUNAL TUBE FEEDING
9 ASIA-PACIFIC ENTERAL FEEDING FORMULA MARKET, BY STAGE
9.1 OVERVIEW
9.2 ADULT
9.3 PEDIATRIC
10 ASIA-PACIFIC ENTERAL FEEDING FORMULA MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 LONG TERM CARE FACILITIES
10.3.1 HOME CARE AGENCIES AND HOSPICES
10.3.2 NURSING HOMES
10.3.3 ASSISTED LIVING FACILITIES
10.4 ASIA PACIFIC
10.4.1 CHINA
10.4.2 INDIA
10.4.3 JAPAN
10.4.4 SOUTH KOREA
10.4.5 AUSTRALIA
10.4.6 SINGAPORE
10.4.7 THAILAND
10.4.8 MALAYSIA
10.4.9 INDONESIA
10.4.10 PHILIPPINES
10.4.11 REST OF ASIA-PACIFIC
11 ASIA-PACIFIC ENTERAL FEEDING FORMULA MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS; ASIA-PACIFIC
12 COMPANY PROFILE
12.1 ABBOTT
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENTS
12.2 NESTL?
12.2.1 COMPANY OVERVIEW
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENTS
12.3 MEIJI HOLDINGS CO., LTD.
12.3.1 COMPANY OVERVIEW
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS
12.4 B. BRAUN MELSUNGEN AG
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENTS
12.5 DANONE NUTRICIA
12.5.1 COMPANY SNAPSHOT
12.5.2 GEOGRAPHICAL PRESENCE
12.5.3 PRODUCT PORTFOLIO
12.5.4 RECENT DEVELOPMENTS
12.6 FRESENIUS SE & CO. KGAA
12.6.1 COMPANY SNAPSHOT
12.6.2 REVENUE ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 RECENT DEVELOPMENTS
12.7 ASIA-PACIFIC HEALTH PRODUCTS, INC.
12.7.1 COMPANY SNAPSHOT
12.7.2 PRODUCT PORTFOLIO
12.7.3 RECENT DEVELOPMENT
12.8 HORMEL FOODS, LLC
12.8.1 COMPANY SNAPSHOT
12.8.2 GEOGRAPHICAL PRESENCE
12.8.3 PRODUCT PORTFOLIO
12.8.4 RECENT DEVELOPMENTS
12.9 MEAD JOHNSON & COMPANY, LLC.
12.9.1 COMPANY SNAPSHOT
12.9.2 GEOGRAPHICAL PRESENCE
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENTS
12.10 MEDLINE INDUSTRIES, INC
12.10.1 COMPANY SNAPSHOT
12.10.2 GEOGRAPHICAL PRESENCE
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENTS
12.11 MEDTRITION, INC.
12.11.1 COMPANY SNAPSHOT
12.11.2 PRODUCT PORTFOLIO
12.11.3 NO RECENT DEVELOPMENTS
12.12 NUTRITIONAL MEDICINALS, LLC
12.12.1 COMPANY SNAPSHOT
12.12.2 GEOGRAPHICAL PRESENCE
12.12.3 PRODUCT PORTFOLIO
12.12.4 NO RECENT DEVELOPMENTS
?
12.13 REAL FOOD BLENDS
12.13.1 COMPANY SNAPSHOT
12.13.2 PRODUCT PORTFOLIO
12.13.3 RECENT DEVELOPMENTS
12.14 VICTUS
12.14.1 COMPANY SNAPSHOT
12.14.2 PRODUCT PORTFOLIO
12.14.3 RECENT DEVELOPMENTS
13 RELATED REPORTS